Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Maravai Lifesciences Holdings (MRVI) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Maravai Lifesciences Holdings (MRVI) over the last 6 years, with Q3 2025 value amounting to $61.6 million.

  • Maravai Lifesciences Holdings' Total Current Liabilities fell 335.12% to $61.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $61.6 million, marking a year-over-year decrease of 335.12%. This contributed to the annual value of $57.0 million for FY2024, which is 3486.65% down from last year.
  • Maravai Lifesciences Holdings' Total Current Liabilities amounted to $61.6 million in Q3 2025, which was down 335.12% from $69.7 million recorded in Q2 2025.
  • In the past 5 years, Maravai Lifesciences Holdings' Total Current Liabilities ranged from a high of $165.3 million in Q1 2021 and a low of $57.0 million during Q4 2024
  • For the 5-year period, Maravai Lifesciences Holdings' Total Current Liabilities averaged around $93.2 million, with its median value being $86.7 million (2022).
  • As far as peak fluctuations go, Maravai Lifesciences Holdings' Total Current Liabilities soared by 4409.69% in 2023, and later tumbled by 5274.31% in 2024.
  • Maravai Lifesciences Holdings' Total Current Liabilities (Quarter) stood at $93.8 million in 2021, then increased by 17.45% to $110.1 million in 2022, then fell by 20.59% to $87.5 million in 2023, then plummeted by 34.87% to $57.0 million in 2024, then grew by 8.08% to $61.6 million in 2025.
  • Its Total Current Liabilities stands at $61.6 million for Q3 2025, versus $69.7 million for Q2 2025 and $63.2 million for Q1 2025.